Research Programs

To tackle the human health challenges that face the world today, the FNIH develops collaborations with top experts from government, industry, academia and the not-for-profit sector and provides a neutral environment where we can work productively toward a common goal.

Programs are displayed in alphabetical order by research topic.

ALL
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Cancer


The Partnership for Accelerating Cancer Therapies (PACT) is a five-year public-private research collaboration totaling $215 million launched by the National Institutes of Health, the FNIH and 12 leading pharmaceutical companies as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers of disease and treatment response — to advance new immunotherapy treatments that harness the immune system to attack cancer. The partnership will be managed by the FNIH.

Diabetes

The Accelerating Medicines Partnership Type 2 Diabetes Project (AMP T2D), is a multi-sector, pre-competitive partnership among government, industry, and nonprofit organizations, the goal of which is to harness collective capabilities, scale and resources toward improving current efforts to develop new therapies for complex, heterogeneous diseases.

Genetics and Genomics

The Genome Research Fund supports genetics and genomics research at the National Human Genome Research Institute (NHGRI).

Genetics and Genomics

Informing the development of the Precision Medicine Initiative.

Global Health

The FNIH and collaborators have and will continue to support the development of consensus best practices guidance and recommendations to inform gene drive research, development, testing and deployment.

Global Health

The FNIH and collaborators are supporting regulatory capacity strengthening activities in anticipation of the potential testing and use of gene drive products.

Global Health
The FNIH periodically convenes technical experts to discuss issues related to the safe and effective use of gene drive technology.
 
Global Health

Gene drive is a mechanism that can promote the preferential inheritance of a beneficial genetic trait, thereby increasing its prevalence in a population. A variety of gene drive mechanisms occur in nature that can cause specific genetic elements to spread throughout populations in varying degrees. Researchers have long sought to harness these naturally occurring gene drive mechanisms to prevent the transmission of mosquito or other insect-borne diseases that pose some of society's most intractable public health problems.

Global Health

The Global Health Fund supports FNIH programs that are designed to alleviate widespread suffering in the developing world. Program focus includes research and training on diseases such as malaria and HIV, as well as conditions like malnutrition that afflict hundreds of millions of people globally.

Heart Disease

The Moderate Alcohol and Cardiovascular Health Trial (MACH15) is a longitudinal, international clinical trial to determine the effects of moderate alcohol use on cardiovascular disease and diabetes.